Bolun Zhou

1.8k total citations · 1 hit paper
47 papers, 1.0k citations indexed

About

Bolun Zhou is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bolun Zhou has authored 47 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 17 papers in Molecular Biology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bolun Zhou's work include Cancer Immunotherapy and Biomarkers (14 papers), Lung Cancer Treatments and Mutations (11 papers) and Lung Cancer Diagnosis and Treatment (8 papers). Bolun Zhou is often cited by papers focused on Cancer Immunotherapy and Biomarkers (14 papers), Lung Cancer Treatments and Mutations (11 papers) and Lung Cancer Diagnosis and Treatment (8 papers). Bolun Zhou collaborates with scholars based in China, United States and Ethiopia. Bolun Zhou's co-authors include Wei Xiong, Zhaoyang Zeng, Xiaoling Li, Can Guo, Yutong Yuan, Guiyuan Li, Shan Zhang, Shugeng Gao, Caiping Ren and Fenglong Bie and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Virology and Scientific Reports.

In The Last Decade

Bolun Zhou

45 papers receiving 1.0k citations

Hit Papers

Intestinal Flora and Disease Mutually Shape the Regional ... 2020 2026 2022 2024 2020 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Intestinal Flora and Disease Mutually Shape the Regional Immune System in the Intestinal Tract
    2020 261 citations Bolun Zhou et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bolun Zhou China 18 478 262 207 193 139 47 1.0k
Lan Li China 16 482 1.0× 227 0.9× 222 1.1× 293 1.5× 142 1.0× 51 1.2k
Mingming Yang China 17 438 0.9× 140 0.5× 180 0.9× 91 0.5× 136 1.0× 80 966
Pei Li China 20 405 0.8× 175 0.7× 178 0.9× 270 1.4× 134 1.0× 89 1.1k
Lei Ding China 25 820 1.7× 330 1.3× 422 2.0× 195 1.0× 114 0.8× 56 1.7k
Robert Suriano United States 17 473 1.0× 189 0.7× 127 0.6× 74 0.4× 168 1.2× 36 1.1k
Huimin Hu China 17 385 0.8× 145 0.6× 69 0.3× 139 0.7× 73 0.5× 70 975
Jing Yu China 20 452 0.9× 321 1.2× 255 1.2× 207 1.1× 174 1.3× 64 1.1k

Countries citing papers authored by Bolun Zhou

Since Specialization
Citations

This map shows the geographic impact of Bolun Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bolun Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bolun Zhou more than expected).

Fields of papers citing papers by Bolun Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bolun Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bolun Zhou. The network helps show where Bolun Zhou may publish in the future.

Co-authorship network of co-authors of Bolun Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Bolun Zhou. A scholar is included among the top collaborators of Bolun Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bolun Zhou. Bolun Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Guo, Wei, Bolun Zhou, Lizhou Dou, et al.. (2025). Single-cell RNA sequencing and spatial transcriptomics of esophageal squamous cell carcinoma with lymph node metastases. Experimental & Molecular Medicine. 57(1). 59–71. 4 indexed citations
3.
Liang, Qing, Yue Peng, Zhenlin Yang, et al.. (2025). Pulmonary macrophage-targeted RNAi and mRNA co-delivery via SORT lipid nanoparticles enhances immunotherapy in lung cancer. Journal of Controlled Release. 390. 114519–114519.
4.
Yang, Zhenlin, Bolun Zhou, Wei Guo, et al.. (2024). Genomic characteristics and immune landscape of super multiple primary lung cancer. EBioMedicine. 101. 105019–105019. 6 indexed citations
5.
Liu, Yang, Fenglong Bie, Guangyu Bai, et al.. (2024). Prognostic model based on B cell marker genes for NSCLC patients under neoadjuvant immunotherapy by integrated analysis of single-cell and bulk RNA-sequencing data. Clinical & Translational Oncology. 26(8). 2025–2036. 1 indexed citations
6.
Zhou, Bolun, Fan Zhang, Wei Guo, et al.. (2024). Five-year follow-up of neoadjuvant PD-1 inhibitor (sintilimab) in non-small cell lung cancer. Journal for ImmunoTherapy of Cancer. 12(8). e009355–e009355. 5 indexed citations
7.
Zhou, Bolun, Ruochuan Zang, Peng Song, et al.. (2023). Association between radiotherapy and risk of second primary malignancies in patients with resectable lung cancer: a population-based study. Journal of Translational Medicine. 21(1). 10–10. 13 indexed citations
8.
Chen, Xiaowei, Guangyu Bai, Ruochuan Zang, et al.. (2023). Utility of 18F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable non‑small cell lung cancer. Translational Oncology. 35. 101725–101725. 6 indexed citations
9.
Hu, Wenshuo, Weijun Wang, Xinyan Wang, et al.. (2023). Plasma metabonomics of classical swine fever virus-infected pigs. Frontiers in Veterinary Science. 10. 1171750–1171750. 1 indexed citations
10.
Zhou, Bolun, Ruochuan Zang, Moyan Zhang, et al.. (2022). Worldwide burden and epidemiological trends of tracheal, bronchus, and lung cancer: A population-based study. EBioMedicine. 78. 103951–103951. 50 indexed citations
11.
Zhou, Bolun, Fenglong Bie, Ruochuan Zang, et al.. (2022). RNA modification writer expression profiles predict clinical outcomes and guide neoadjuvant immunotherapy in non-small cell lung cancer. EBioMedicine. 84. 104268–104268. 30 indexed citations
12.
Guo, Wei, Bolun Zhou, Zhenlin Yang, et al.. (2022). Integrating microarray-based spatial transcriptomics and single-cell RNA-sequencing reveals tissue architecture in esophageal squamous cell carcinoma. EBioMedicine. 84. 104281–104281. 44 indexed citations
13.
Zhou, Bolun, Ruochuan Zang, Moyan Zhang, et al.. (2022). Identifying novel tumor-related antigens and immune phenotypes for developing mRNA vaccines in lung adenocarcinoma. International Immunopharmacology. 109. 108816–108816. 6 indexed citations
14.
Zhou, Bolun & Shugeng Gao. (2021). Construction and validation of a novel immune and tumor mutation burden-based prognostic model in lung adenocarcinoma. Cancer Immunology Immunotherapy. 71(5). 1183–1197. 8 indexed citations
15.
Bie, Fenglong, Nan Sun, Ruochuan Zang, et al.. (2021). Comprehensive analysis of PD-L1 expression, tumor-infiltrating lymphocytes, and tumor microenvironment in LUAD: differences between Asians and Caucasians. Clinical Epigenetics. 13(1). 229–229. 11 indexed citations
16.
Zhou, Bolun & Shugeng Gao. (2021). Comprehensive Analysis of Clinical Significance, Immune Infiltration and Biological Role of m6A Regulators in Early-Stage Lung Adenocarcinoma. Frontiers in Immunology. 12. 698236–698236. 8 indexed citations
17.
Yi, Xiaoping, Yingzi Liu, Bolun Zhou, et al.. (2020). Incorporating SULF1 polymorphisms in a pretreatment CT-based radiomic model for predicting platinum resistance in ovarian cancer treatment. Biomedicine & Pharmacotherapy. 133. 111013–111013. 34 indexed citations
18.
Yao, Lixia, et al.. (2020). LncRNA MIAT/miR-133a-3p axis regulates atrial fibrillation and atrial fibrillation-induced myocardial fibrosis. Molecular Biology Reports. 47(4). 2605–2617. 53 indexed citations
19.
Zhou, Bolun, Wei Zhu, Xingjun Jiang, & Caiping Ren. (2019). RASAL2 Plays Inconsistent Roles in Different Cancers. Frontiers in Oncology. 9. 1235–1235. 18 indexed citations
20.
Zhou, Bolun, Wei Zhu, & Caiping Ren. (2019). First steps to regulate advertising of areca nut in China. The Lancet Oncology. 20(5). 615–616. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lan Li Breakdown of academic impact, for papers by Mingming Yang Breakdown of academic impact, for papers by Pei Li Breakdown of academic impact, for papers by Lei Ding Breakdown of academic impact, for papers by Robert Suriano Breakdown of academic impact, for papers by Huimin Hu Breakdown of academic impact, for papers by Jing Yu
Rankless by CCL
2026